XML 111 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
CAPITAL STOCK (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Common Stock Outstanding
The following table provides changes to the Company’s common shares outstanding for the years ended December 31, 2023, 2022, and 2021:
For the Year Ended December 31,
202320222021
Balance, beginning of year311,559,149 346,930,765 377,482,630 
Shares issued for stock-based compensation plans:
Treasury shares issued2,016 1,996 3,133 
Common shares issued725,914 791,381 649,231 
Treasury shares acquired(8,711,178)(36,164,993)(31,204,229)
Balance, end of year303,575,901 311,559,149 346,930,765 
Schedule of Reconciliation of Components of Basic and Diluted Net Income (Loss) Per Common Share
The following table provides a reconciliation of the components of basic and diluted net income per common share for the years ended December 31, 2023, 2022, and 2021:
 202320222021
 IncomeSharesPer ShareIncomeSharesPer Share
Income
SharesPer Share
 (In millions, except per share amounts)
Basic:
Income attributable to common stock
$2,855 308 $9.26 $3,674 332 $11.05 $973 374 $2.60 
Effect of Dilutive Securities:
Stock compensation awards
$— $(0.01)$— $(0.03)$— $(0.01)
Diluted:
Income attributable to common stock
$2,855 309 $9.25 $3,674 333 $11.02 $973 375 $2.59 
Schedule of Description of Stock Based Compensation Plans and Related Costs The following table summarizes the Company’s stock-settled and cash-settled compensation costs for the years ended December 31, 2023, 2022, and 2021:
For the Year Ended December 31,
202320222021
 (In millions)
Stock-settled and cash-settled compensation expensed:
Lease operating expenses
$27 $82 $39 
Exploration
29 10 
General and administrative
50 193 108 
Total stock-settled and cash-settled compensation expensed
84 304 157 
Stock-settled and cash-settled compensation capitalized13 44 18 
Total stock-settled and cash-settled compensation costs$97 $348 $175 
Schedule of Stock Options Activities
The following table summarizes stock option activity for the years ended December 31, 2023, 2022, and 2021:
 202320222021
 Shares
Under Option
Weighted Average
Exercise Price
Shares
Under Option
Weighted Average
Exercise Price
Shares
Under Option
Weighted Average
Exercise Price
(In thousands, except exercise price amounts)
Outstanding, beginning of year2,078 $57.71 3,012 $63.79 3,537 $72.10 
Exercised(12)42.38 (99)42.09 — — 
Forfeited— — (2)49.10 — — 
Expired(601)80.53 (833)81.56 (525)119.83 
Outstanding, end of year(1)
1,465 48.48 2,078 57.71 3,012 63.79 
Expected to vest— — — — — — 
Exercisable, end of year(1)
1,465 48.48 2,078 57.71 3,012 63.79 
(1)As of December 31, 2023, options exercisable and outstanding had a weighted average remaining contractual life of 3.1 years and aggregate intrinsic value of $33,000.
Schedule of Restricted Stock and Restricted Stock Units Activity
The following table summarizes stock-settled restricted stock unit activity for the years ended December 31, 2023, 2022, and 2021:
202320222021
UnitsWeighted
Average  Grant-Date  Fair Value
UnitsWeighted
Average  Grant-Date  Fair Value
UnitsWeighted
Average  Grant-Date  Fair Value
(In thousands, except per share amounts)
Non-vested, beginning of year1,885 $23.08 2,073 $19.98 1,552 $28.43 
Granted661 41.60 847 29.90 1,506 16.46 
Vested(3)
(975)23.31 (978)22.39 (857)29.13 
Forfeited(69)32.44 (57)23.49 (128)19.78 
Expired
(22)27.81 — — — — 
Non-vested, end of year(1)(2)
1,480 30.69 1,885 23.08 2,073 19.98 
(1)As of December 31, 2023, there was $15 million of total unrecognized compensation cost related to 1,479,880 unvested stock-settled restricted stock units.
(2)As of December 31, 2023, the weighted-average remaining life of unvested stock-settled restricted stock units is approximately 0.6 years.
(3)The grant date fair values of the stock-settled awards vested during 2023, 2022, and 2021 were approximately $23 million, $22 million, and $25 million, respectively.
The following table summarizes cash-settled restricted stock phantom unit activity for the years ended December 31, 2023, 2022, and 2021:
For the Year Ended December 31,

202320222021
(In thousands)
Non-vested, beginning of year5,709 6,402 4,423 
Adjustment from ALTM transaction(1)
— 143 — 
Granted(2)
1,972 2,568 4,441 
Vested(2,851)(2,970)(2,049)
Forfeited(340)(434)(413)
Expired
(12)— — 
Non-vested, end of year(3)
4,478 5,709 6,402 
(1)Following the BCP Business Combination, certain employees were granted restricted stock phantom units based on APA’s common stock price to replace the equivalent value in restricted stock phantom units based on ALTM’s common stock price.
(2)Restricted stock phantom units granted during 2023, 2022, and 2021 included 1,972,116, 2,512,602, and 4,375,546 awards, respectively, based on the per-share market price of APA common stock. Restricted stock phantom units granted during 2022 and 2021 included 55,546 and 65,327 awards, respectively, based on the per-share market price of ALTM common stock prior to the deconsolidation of Altus on February 22, 2022.
(3)The outstanding liability for the unvested cash-settled restricted stock phantom units that had not been recognized as of December 31, 2023 was approximately $54 million.
The following table summarizes cash-settled conditional restricted stock phantom unit activity for the years ended December 31, 2023, 2022, and 2021:
For the Year Ended December 31,
202320222021
 (In thousands)
Non-vested, beginning of year4,835 4,531 3,417 
Granted1,536 1,676 1,782 
Vested(1,593)(656)(76)
Forfeited(99)(106)(240)
Expired(50)(610)(352)
Non-vested, end of year(1)
4,629 4,835 4,531 
(1)As of December 31, 2023, the outstanding liability for the unvested cash-settled conditional restricted stock phantom units that had not been recognized was approximately $24 million.